AUTHORS
Oluwadara Carissa Ogunwale, Nahom Mossazghi, MS2, Sossena Wood, PhD, BSc3, Li Wang4, Abigail Cartus5, Maria Mori Brooks, PhD6, Julia Z Xu, MD, MScGH7, Laura M. DeCastro, MD8, Eliza Miller9, Beth Snitz10, Caterina Rosano, MD11, Enrico M Novelli, MD12, Olubusola Oluwole, MD13
AFFILIATIONS
1 Emory University, Atlanta, Georgia, United States
2 Carnegie Mellon University, Pittsburgh, Pennsylvania, United States
3 Carnegie Mellon University, Pittsburgh, Pennsylvania, United States
4 University of Pittsburgh, Pittsburgh, Pennsylvania, United States
5 University of Pittsburgh, Pittsburgh, Pennsylvania, United States
6 University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
7 University of Pittsburgh, Pittsburgh, Pennsylvania, United States, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
8 University of Pittsburgh, Pittsburgh, Pennsylvania, United States, University of Pittsburgh, Pittsburgh, Pennsylvania, United States
9 University of Pittsburgh, Pittsburgh, Pennsylvania, United States
10 University of Pittsburgh, Pittsburgh, Pennsylvania, United States
11 University of Pittsburgh, Pittsburgh, Pennsylvania, United States
12 University of Maryland Medical System, Baltimore, Maryland, United States
13 Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania, United States, University of Pittsburgh, Pittsburgh, Pennsylvania, United States, Vascular Medicine Institute, Pittsburgh, Pennsylvania, United States
ABSTRACT
Background: Neurocognitive impairment is a common complication of sickle cell disease (SCD) that adversely affects education, employment, treatment adherence, and quality of life. Although overt and silent/covert cerebral infarcts contribute to cognitive decline, deficits in processing speed, memory, and executive function also occur in adults without identifiable infarction, suggesting additional vascular mechanisms. Pulse pressure (PP), a surrogate marker of arterial stiffness, has been associated with cerebral small-vessel injury and cognitive decline in the general population. This relationship may be particularly relevant in SCD, where chronic anemia, high-output physiology, endothelial dysfunction, and vasculopathy alter arterial hemodynamics. However, the association between long-term PP exposure and cognitive function in adults with SCD remains poorly defined. We therefore aimed to determine the association between longitudinal systolic blood pressure (SBP) and PP with neurocognitive performance in adults with SCD.
Methods: This secondary analysis was conducted within a longitudinal prospective cohort study of neuroimaging and neurocognitive outcomes in adults (≥18 years old) with SCD (NCT02946905). The exposures of interest were longitudinal SBP and PP. The outcomes were four neurocognitive measures: the Digit Symbol Substitution Test (DSST) scaled score (processing speed), the Hopkins Verbal Learning Test–Revised (HVLT-R) total recall t-score (verbal learning), and a two execution function composite scores derived from the Delis–Kaplan Executive Function System (D-KEFS). The two- and four-component executive-function composite scores were calculated by summing selected scaled scores from the D-KEFS Trail Making, Color-Word Interference, and Verbal Fluency Category Switching tests. All scores included in this study were adjusted for age at the time of test administration, and higher scores indicated better cognitive performance. Mixed-effects models with participant-specific random intercepts and slopes were initially used to evaluate SBP and PP trajectories. Since neither SBP nor PP changed significantly over time, each participant's mean SBP and PP across follow-up were used as the longitudinal exposure measures. A linear regression model was then used to test the associations between mean SBP or PP and each of the four neurocognitive outcomes separately. Adjusted models included patients’ age at baseline, smoking status, and years of education.
Result: A total of 75 participants with SCD (49% HbSS, 32% HbSC, 15% HbS/ b+ and 4% HbS/b0) were included in this analysis, with a mean age of 36 ± 12 years and a median of 36 blood pressure measurements (interquartile range, 22-72) before neurocognitive assessment. Thirty-four participants (45%) had ever smoked, 20 (27%) had never smoked, and smoking status was unavailable for 21 (28%). Mean baseline SBP and PP were 118 ± 15 mm Hg and 50 ± 13 mm Hg, respectively. Mean DSST, HVLT-R, 2-component executive-function, and 4-component executive-function scores were 8.4 ± 3.0, 39 ± 9.9, 14 ± 5.0, and 30 ± 10, respectively. Mean SBP was not associated with any cognitive outcomes in unadjusted or adjusted analyses. Each 1-mmHg increase in mean PP was associated with a 0.40-unit decrease in four-component executive function composite (b=-0.40, 95% CI, -0.78 to -0.03; p=0.04). After accounting for age, smoking status, and education, the association was attenuated and no longer significant (β= -0.32; 95% CI, -0.74 to 0.09; p=0.122). Higher mean PP showed a similar inverse pattern with the 2-component executive-function composite, but the association was not statistically significant (adjusted β = -0.18; 95% CI, -0.40 to 0.04; p=0.10). PP was not associated with processing speed or verbal learning.
Conclusion: The results show that higher mean PP over time was associated with lower executive-function scores in the unadjusted analysis. Long-term mean SBP was not associated with processing speed, verbal learning, or executive function. These findings suggest that PP may serve as a practical marker to identify patients at increased risk for vascular-related cognitive dysfunction. These findings support further study of PP alongside direct measures of arterial stiffness and cerebral small-vessel injury and may ultimately inform earlier cognitive screening and vascular risk-reduction strategies in SCD.
DISCLOSURES
Oluwadara Carissa Ogunwale: No relevant conflicts of interest to declare.